Exhibitors 2021


VoiceMed

VoiceMed

VoiceMed One is the first CE mark cough test for COVID19 that is rapid, scalable and cost effective.
It works combining cough recording with artificial intelligence, extracting related vocal biomarkers of COVID19, and giving the result whether positive or negative.
Our innovative technology has a patent pending from the Italian Pantent Office.
VoiceMed One is the first application of VoiceMed platform, a platform for screening, early diagnosis of diseases in a simple, fast and scalable way, analyzing voice recordings through artificial intelligence. The other products being analyzed, provide remotely monitoring of voice biomarkers linked to wellness such as Health Check or chronic diseases (COPD).




VoiceMed

Arianna Arienzo

Graduated with a Master of Science in Business Administration, and with a Fulbright entrepreneurship and innovation program in Silicon Valley, Arianna has developed her professional career in several countries including Spain, Ecuador and the United States. As a first consultant in new technologies at Accenture, she has subsequently developed her entrepreneurial path in the field of digital health, combining her strong family passion for the health sector with her expertise in artificial intelligence. In fact, Arianna is the daughter of two nationally renowned pulmonologists. To date Arianna is the founder and CEO of VoiceMed, a startup focused on early diagnosis and remote monitoring through voice analysis. Her goal is to facilitate access to health care, giving everyone the opportunity to know their state of health.



 Health
  J.1.11 (pav. J) - Arianna Arienzo
 2021

Back
 
Data updated on 2021-11-09 - 11.51.35 am